Showing results (871-880 of 928) with videos related to
Sort By:
Pageof 93
Muscle & Nerve|February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravisSrikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.Human Molecular Genetics|May 6, 2010
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regionsTao Yu, Zhongyou Li, Zhengping Jia, et al.Annals of Clinical and Translational Neurology|March 11, 2020
Targeted gene panel use in 2249 neuromuscular patients: the Australasian referral center experienceSarah J Beecroft, Kyle S Yau, Richard J N Allcock, et al.Leukemia|January 3, 2017
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cellsD T Saenz, W Fiskus, Y Qian, et al.Leukemia & Lymphoma|July 21, 2012
Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1Kasyapa S Chitta, Aneel Paulus, Sikander Ailawadhi, et al.Cancer Research|November 24, 2001
Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCRG R Anderson, B M Brenner, H Swede, et al.American Journal of Human Genetics|November 27, 2010
Dominant mutations in KBTBD13, a member of the BTB/Kelch family, cause nemaline myopathy with coresNyamkhishig Sambuughin, Kyle S Yau, Montse Olivé, et al.The Journal of Cell Biology|May 27, 2009
Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actinKristen J Nowak, Gianina Ravenscroft, Connie Jackaman, et al.Neurology|October 21, 2022
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia GravisVera Bril, Andrzej Szczudlik, Antanas Vaitkus, et al.Leukemia|December 22, 2018
Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AMLDyana T Saenz, Warren Fiskus, Taghi Manshouri, et al.Pageof 93